Acute and late effects of multimodal therapy on normal tissues.
The increasing use of combined radiation, chemotherapy, and surgery had led to an increased incidence of acute and late complications. The complications are, in general, similar to those seen with each modality alone, but occur with increased incidence. Enhanced effects of combined radiation and surgery are modest in number and consist primarily of problems with wound healing and fibrosis, as well as late gastrointestinal damage. Combinations of radiotherapy and chemotherapy have shown a greater degree of enhanced acute and late reactions. Drugs, such as actinomycin-D and Adriamycin, are particularly dangerous if the marked enhancement of radiation effects caused by the drugs in almost all organs is not appreciated and the radiation dose not adjusted accordingly. Proper selection of drugs can lead to enhanced local control by radiotherapy and/or surgery, as well as eradication of microscopic distant metastases, without increased normal tissue injury. Late induction of malignancy can occur with either radiation or chemotherapy alone and, in some cases, this appears to be enhanced when they are combined.
D000970:Antineoplastic Agents / Q000009:adverse effects*; D003609:Dactinomycin / Q000009:adverse effects; D004317:Doxorubicin / Q000009:adverse effects; D005260:Female; D006801:Humans; D008297:Male; D009369:Neoplasms / Q000628:therapy*; D009378:Neoplasms, Multiple Primary / Q000139:chemically induced / Q000209:etiology; D009381:Neoplasms, Radiation-Induced / Q000209:etiology; D011183:Postoperative Complications / Q000209:etiology*; D011838:Radiation-Sensitizing Agents / Q000009:adverse effects; D011878:Radiotherapy / Q000009:adverse effects*; D013997:Time Factors
D000970:Antineoplastic Agents; D011838:Radiation-Sensitizing Agents; D003609:Dactinomycin; D004317:Doxorubicin